320 related articles for article (PubMed ID: 16232126)
1. Towards the application of proteomics in renal disease diagnosis.
Vidal BC; Bonventre JV; I-Hong Hsu S
Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
[TBL] [Abstract][Full Text] [Related]
2. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
3. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
4. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
5. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
6. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
Dihazi H; Müller GA
Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
[TBL] [Abstract][Full Text] [Related]
7. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.
Thongboonkerd V
Mol Biosyst; 2008 Aug; 4(8):810-5. PubMed ID: 18633482
[TBL] [Abstract][Full Text] [Related]
8. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
9. Value of proteomics applied to the follow-up in stem cell transplantation.
Weissinger EM; Mischak H; Ganser A; Hertenstein B
Ann Hematol; 2006 Apr; 85(4):205-11. PubMed ID: 16463156
[TBL] [Abstract][Full Text] [Related]
10. A streamlined approach to high-throughput proteomics.
Stephens AN; Quach P; Harry EJ
Expert Rev Proteomics; 2005 Apr; 2(2):173-85. PubMed ID: 15892563
[TBL] [Abstract][Full Text] [Related]
11. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
Mischak H; Delles C; Klein J; Schanstra JP
Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
[TBL] [Abstract][Full Text] [Related]
12. [Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology].
Opatrný K
Vnitr Lek; 2004 Jul; 50(7):556-63. PubMed ID: 15323265
[TBL] [Abstract][Full Text] [Related]
13. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
Fliser D; Wittke S; Mischak H
Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
Fang X; Balgley BM; Lee CS
Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
[TBL] [Abstract][Full Text] [Related]
15. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
16. Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications.
Fagerquist CK; Bates AH; Heath S; King BC; Garbus BR; Harden LA; Miller WG
J Proteome Res; 2006 Oct; 5(10):2527-38. PubMed ID: 17022624
[TBL] [Abstract][Full Text] [Related]
17. Challenges of genomics and proteomics in nephrology.
Stojnev S; Pejcic M; Dolicanin Z; Velickovic LJ; Dimov I; Stefanovic V
Ren Fail; 2009; 31(8):765-72. PubMed ID: 19814648
[TBL] [Abstract][Full Text] [Related]
18. Characterization and quantitation of membrane proteomes using multidimensional MS-based proteomic technologies.
Blonder J; Conrads TP; Veenstra TD
Expert Rev Proteomics; 2004 Aug; 1(2):153-63. PubMed ID: 15966810
[TBL] [Abstract][Full Text] [Related]
19. Role and challenges of proteomics in pharma and biotech: technical, scientific and commercial perspective.
Qoronfleh MW
Expert Rev Proteomics; 2006 Apr; 3(2):179-95. PubMed ID: 16608432
[TBL] [Abstract][Full Text] [Related]
20. Analytical considerations for mass spectrometry profiling in serum biomarker discovery.
Whiteley GR; Colantonio S; Sacconi A; Saul RG
Clin Lab Med; 2009 Mar; 29(1):57-69. PubMed ID: 19389551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
